Question and Answers

Yes.
TMR® acts on both nociceptive pain and neuropathic pain. There is evidence in the literature and in particular in the scientific article by Prof. Piaggesi, entitled “Safety and effectiveness of therapeutic magnetic resonance in the management of postsurgical lesion of the diabetic foot” (http://www.ncbi.nlm.nih.gov/pubmed/25724594) where efficacy in pain reduction has been demonstrated during the treatment period with TMR® and for a few months after the end of therapy.

Therapy is administered in sessions lasting about 30 minutes, 1 to 4 times a day, for a period varying between 4 and 8 weeks, depending on the severity and type of pathology. It is possible to prolong the therapy for a more lasting effect, especially with regard to pain and orthopedic diseases.

DIAPASON® is a medical device designed for home use. The patient can rent it monthly or purchase it by contacting our office, which will provide all the information necessary to carry out the procedure. The product is delivered directly to the patient’s home by one of our trusted couriers and the rental cost includes THERESON Customer Service which will be available to the patient for any need.

While using DIAPASON®, local phenomena such as redness or mild tingling may occur. These manifestations indicate a correct functioning of the device and are due to the natural reparative response process of biological tissues.

Two clinical studies have been completed:
One multi-center, with the participation of the Cisanello University Hospital of Pisa, the Cà Foncello Hospital of Treviso and the Pederzoli Nursing Home in Peschiera del Garda.
One monocentric at the Cisanello University Hospital of Pisa, on two groups of patients with post-surgical diabetic foot lesions.

No, there are differences.
Although both methods are based on electromagnetic fields, TMR® uses a stimulation signal with variable frequencies, in the 0-250 Hz range, optimized to induce specific cellular responses for ulcer healing. The signal is formed by a triangular-shaped pulse sequence of variable amplitudes, which promote cell replication mechanisms and the reduction of oxidative stress (evidence obtained in vitro and published in June 2015 in the international specialist journal “Journal of Tissue Engineering and Regenerative Medicine”).

DIAPASON® is a patented device (# 0001406269) entitled “Apparatus for therapeutic treatment with pulsed electromagnetic waves resonating.” A further patent (# TO2014A000505) was also filed entitled “System for therapeutic treatments with electromagnetic waves”, for which we received a favorable research report that allowed us to proceed with the extension of the application at European level.

Yes.
In certain cases there is a reduction in pain only from the second week of treatment.


Pursuant to the circular of the Ministry of Health of 03/28/2013, THERESON S.p.A. warns the user that the contents on the site (texts, images, photos, etc.) are aimed exclusively at healthcare professionals and have an informative content only. This information cannot therefore be classified as advertising.
THERESON S.p.A. disclaims any responsibility for consultations by subjects other than professional operators.

Request information

Our technicians, salespeople and doctors are at your disposal for any clarification. We invite you to fill in the form or contact us directly.


Fill in the requested info:

CompanyPrivateMedical facilityInvestor